Click here for YNHH home page.


Sign up for HealthLINK.

Can we help?

Follow up on this month's He@lthLINK

 


Phone Numbers

Directory assistance
(203) 688-4242

Patient information
(203) 688-4177

Adult emergency
(203) 688-2222

Children's emergency
(203) 688-3333

Admitting
(203) 688-2221

Children's admitting
(203) 688-3331



Mailing address:
Yale-New Haven Hospital
20 York Street
New Haven, CT
06510-3202





Yale-New Haven Hospital, New Haven, Connecticut, USA HealthLINK: Women's Health
November 3, 2000

News this month
Testosterone therapy may benefit post-menopausal women

A dose of testosterone may be a good thing for post-menopausal women undergoing hormone replacement therapy. Estrogen mixed with methyltestosterone, also known as androgen, improved sexual desire and response in women who were dissatisfied with estrogen alone, according to a study published in The Journal of Reproductive Medicine.

"Giving estrogen alone to menopausal women helped a little bit, but gradually over time the effectiveness was lost," said Philip Sarrel, MD, professor of obstetrics and gynecology at the Yale School of Medicine, and principal investigator for the study. "What we found in our study was the missing part—the lack of androgen replacement."

The study enlisted volunteers dissatisfied with hormone replacement therapy and experiencing hot flashes, vaginal dryness, decreased libido, painful intercourse and fatigue.

Study conducted on mid-life women
For the purposes of this double-blind, randomized study, the investigators enlisted 20 volunteers, ages 45 to 55 years, who were dissatisfied with the effectiveness of hormone replacement therapy in relieving menopausal symptoms. All women in the study were naturally or surgically menopausal. They had taken estrogen replacement therapy for an average duration of more than a year, but they were still experiencing menopausal symptoms such as hot flashes, vaginal dryness, decreased libido, painful intercourse and fatigue.

During this study, Dr. Sarrel gave half of the group conventional estrogen replacement, and he added testosterone to the estrogen for the other half. All of the subjects successfully completed eight weeks of treatment. Investigators measured menopausal symptoms and quality of life at regular intervals during the study using the Menopausal Symptom Scale, which evaluates hot flashes, sleep disturbances, memory changes, depression, anxiety and painful intercourse. Sexual function was evaluated with a 10-question Sexual Activity and Libido Scale. Investigators also drew regular blood samples to measure the levels of various hormones and proteins in the subjects’ blood, including estradiol, estrone, sex hormone binding globulin (SHBG) and beta-endorphin.

Women taking estrogen plus testosterone reported significant increases in sexual sensation and desire.

Testosterone benefited all subjects
The women taking estrogen plus testosterone reported significant increases in sexual sensation and desire and more frequent intercourse after four weeks and again at eight weeks after starting therapy. All the estrogen-treated women except one reported "little" improvement in sensation and desire. In the estrogen-androgen group, six out of nine women described improvements as "quite a bit" or higher. Other symptoms such as vaginal dryness or pain during intercourse, hot flashes and disturbed sleep did not change significantly with either treatment.

Levels of SHBG, a protein that binds most of a woman’s natural testosterone, increased in the estrogen group and decreased in the estrogen-androgen group. Lower levels of SHBG indicate higher levels of free androgens in the bloodstream. The investigators concluded that the beneficial effect of the estrogen-androgen combination on sexual function could be attributed either to the androgen in the medication or to the higher levels of free androgens in the bloodstream of those women taking the estrogen-androgen therapy.

Many previous studies corroborate the role of androgens in enhancing sexual desire in women and men. Studies have not, however, demonstrated any significant improvement with estrogen therapy although this hormone does play a beneficial role in relieving vaginal dryness and atrophy. In this study, sexual function improved in the estrogen-androgen women even though estrogen levels were lower than before the study, further demonstrating estrogens do not play a significant role in influencing sexual desire in women.



Physician Referral Online

A free and confidential service
of Yale-New Haven Hospital.

Physician Referral Online
Using your own criteria, you can request information from a database of 900 area physicians who have registered to participate.

Request an appointment
We would be happy to assist you in scheduling an appointment with a member of the hospital's medical staff. Use the link above or call:

203-688-2000
or toll free
1-888-700-6543
to talk with a referral coordinator.


Philip Sarrel, MD

Role of androgens underplayed

Much of the focus of treatment for post-menopausal symptoms has been on estrogen, which is certainly an important and beneficial therapy for many women; but in fact, women produce more testosterone than estrogens daily, and their bodies convert the testosterone to estrogen. In adult women, testosterone has long been known to play a key role in sexuality, in the prevention of bone loss and increased bone density. Like estrogen, testosterone production drops significantly after menopause. Yet the impact of post-menopausal testosterone decline has been far less studied than that of estrogen.

"In adult women, testosterone has long been known to play a key role in sexuality, in the prevention of bone loss and increased bone density."

In my practice, we have used this hormone successfully to treat not only post-menopausal women but also women in their reproductive years who have experienced a loss of interest in sex. There’s a straightforward biochemical reason why some women who are on estrogen either for birth control purposes or to treat menopausal symptoms might especially need testosterone: Most of a woman's natural testosterone supply is already "bound" to a protein called sex hormone binding globulin or SHBG. Only about one percent of the body’s supply is available to act on tissues.

Estrogen given alone triggers the production of more SHBG, which then binds up more testosterone. The SHBG phenomenon explains the fatigue and loss of libido that may accompany estrogen therapy, so a woman who was not lacking in testosterone before she started hormone replacement therapy may become deficient during the course of therapy.

"Women who have experienced a decrease in sexual interest and pleasure might want to talk with their physicians about the possibility of taking androgen supplements."

Who should consider taking it?
Women who have experienced a decrease in sexual interest and pleasure might want to talk with their physicians about the possibility of taking androgen supplements. There is a blood test to measure the presence of free testosterone in your body, and your physician will be able to determine if you are deficient.

In the study published in the Journal of Reproductive Medicine, our subjects were otherwise healthy post-menopausal women who rated their prior interest in sex as moderate to high. There are some women who report a lifelong low level of desire, and there may be many other factors in addition to androgen deficiency that contribute to this profile.

"…testosterone is a key factor in maintaining muscular strength and appetite. Some women also report improved concentration and restored feelings of well-being."

The benefits
Our subjects reported their experience to be like the turning off of a switch in their bodies. Their loss of libido was distressing to them and threatened their sense of well-being. After treatment with an estrogen-androgen compound, these women without exception reported "feeling like themselves" again. In addition to improving sexual desire, testosterone is a key factor in maintaining muscular strength and appetite. Some women also report improved concentration and restored feelings of well-being.

A word of caution
There are adverse effects if women receive an excess of androgens. These include skin reactions such as an increase in oiliness and acne, an increase in body and facial hair and voice changes. It’s important women be monitored by their physicians to ensure they are receiving the appropriate dose.

Choices for supplementing testosterone
Testosterone is available in a number of forms. Estratest ®, which contains both estrogen and testosterone, has been available by prescription for decades and has a long history of clinical safety and efficacy. There is currently a testosterone patch on the market for men, and within a few years, we expect this will be available for women as well. There are also gels and creams that contain testosterone, but we are unsure of how much of the active ingredient in these creams enters the bloodstream, so I have been hesitant to prescribe any of these until we have the results of long-term studies.

Estratest is currently the standard treatment. I advise my patients to take the medication for a minimum of six weeks before deciding whether it is working effectively since it can take a while before any effect is noticed.

Dr. Sarrel is an attending obstetrician/gynecologist at Yale-New Haven Hospital and a professor of obstetrics and gynecology at the Yale University School of Medicine.


Subscribe to HealthLink.

Other related links.


Copyright 1999-2008.
Top of Page. Y-NHH. YNHHS. Site Editor.

Home page
Staff directory
Directions and parking
Online resources
Yale New Haven Health System
  Need a doctor?
Search
Comments
Top of page
Yale-New Haven Medical Center